Category: Respiratory Syncytial Virus (RSV)

January 31, 2024

National Perinatal Association 2024 Respiratory Syncytial Virus (RSV) Prevention Clinical Practice Guideline: Clinical Presentation, Prevention Strategies, and Social Impacts in Children: An Evidence-Based Interdisciplinary Collaboration
December 31, 2023

New Advances in the Prevention of RSV Infection
December 31, 2023

Protecting Infants from RSV: Understanding Guidance on New Prevention Tools
September 30, 2023

Immunization Umbrella Options to Reduce the Burden of RSV
September 30, 2023

CDC, FDA Issue New RSV Immunization Recommendations
June 30, 2023

CDC Committee Tackles Childhood Immunizations
April 30, 2023

Managing RSV’s Indirect Impact
April 30, 2023

RSV Vaccine to Get Priority Review by the FDA
March 31, 2023

Emily’s RSV Story
February 28, 2023

Highlights from the 39th Annual Conference Advances in Therapeutics and Technology: Critical Care of Neonates, Children, and Adults Ontario, CA
December 31, 2022

Seniors Gain Access to Preventive COVID-19 Treatment
December 31, 2022

RSV, COVID-19, and Influenza A: Are We on the Verge of Viral Armageddon?
November 30, 2022

Call to Action: RSV is a Serious Concern: A National Response is Urgently Needed
October 31, 2022

Vaccines and Preventive Monoclonal Antibodies: What is the Difference?
July 31, 2022

Respiratory Syncytial Virus Takes a Toll on Families